Dandona Finds Triple Therapy Helps Patients with Type 1 Diabetes

Paresh Dandona, MD, PhD, Distinguished Professor of medicine and chief of the Division of Endocrinology, Diabetes and Metabolism, has found that treating patients who have Type 1 diabetes with insulin, liraglutide and dapagliflozin leads to impressive improvements in blood glucose control and weight loss.